Solving Problems Posed by Large Molecules
Pharma IQ: In predictive toxicology what difference does the small molecule versus
large molecule make?
Stephen Kirk: The biggest difference is with regards to the small molecule there’s more of a structured process for predictive pre-clinical toxicological studies and you’re looking more for kind of off target toxicity, whereas with a larger molecule it’s very specific, so you’re looking more for an exaggerated pharmacology type response and looking for
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.